94 related articles for article (PubMed ID: 9818705)
1. Autoreactive antibodies following autologous peripheral blood stem cell transplantation.
Ishikawa F; Shigematsu H; Gondo H; Okamura T; Niho Y
Bone Marrow Transplant; 1998 Oct; 22(7):729-31. PubMed ID: 9818705
[TBL] [Abstract][Full Text] [Related]
2. Ulcerative colitis after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Koike K; Kohda K; Kuga T; Nakazawa O; Ando M; Takayanagi N; Matsunaga T; Sakamaki S; Niitsu Y
Bone Marrow Transplant; 2001 Sep; 28(6):619-21. PubMed ID: 11607778
[TBL] [Abstract][Full Text] [Related]
3. Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma.
Butch AW; Badros A; Desikan KR; Munshi NC
Bone Marrow Transplant; 2001 Mar; 27(6):663-6. PubMed ID: 11319600
[TBL] [Abstract][Full Text] [Related]
4. Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma.
Toubai T; Hirate D; Shono Y; Ota S; Ibata M; Mashiko S; Sugita J; Shigematsu A; Miura Y; Kato N; Umehara S; Kahata K; Tsutsumi Y; Iwao N; Toyoshima N; Tanaka J; Asaka M; Imamura M
Int J Lab Hematol; 2008 Feb; 30(1):75-81. PubMed ID: 18190473
[TBL] [Abstract][Full Text] [Related]
5. [Development of Hodgkin's disease four years after autologous peripheral blood stem cell transplantation for multiple myeloma].
Fujii H; Iwai T; Ueda Y; Nakagawa H
Rinsho Ketsueki; 2000 Dec; 41(12):1267-72. PubMed ID: 11201152
[TBL] [Abstract][Full Text] [Related]
6. A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis.
Gandhi M; Jestice H; Scott M; Bloxham D; Bass G; Craig J; Marcus R
Bone Marrow Transplant; 1999 Aug; 24(4):369-75. PubMed ID: 10467325
[TBL] [Abstract][Full Text] [Related]
7. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
[TBL] [Abstract][Full Text] [Related]
9. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
11. Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma.
Arora M; McGlave PB; Burns LJ; Miller JS; Barke JN; Defor TE; Weisdorf DJ
Bone Marrow Transplant; 2005 Jun; 35(12):1133-40. PubMed ID: 15834435
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmune thrombocytopenia following syngeneic peripheral blood stem cell transplantation].
Nishio M; Sawada K; Koizumi K; Endoh T; Takashima H; Hashimoto H; Haseyama Y; Katagiri E; Fukada Y; Takano H; Tarumi T; Yasukouchi T; Koike T
Rinsho Ketsueki; 1998 Aug; 39(8):580-5. PubMed ID: 9785976
[TBL] [Abstract][Full Text] [Related]
13. Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation.
Hovenga S; de Wolf JT; Guikema JE; Klip H; Smit JW; Smit Sibinga CT; Bos NA; Vellenga E
Bone Marrow Transplant; 2000 Apr; 25(7):723-8. PubMed ID: 10745257
[TBL] [Abstract][Full Text] [Related]
14. Refractory thrombocytopenia due to anti-PLA1 antibodies following autologous peripheral blood stem cell transplantation: case report and review of literature.
Roy V; Verfaillie CM
Bone Marrow Transplant; 1996 Jan; 17(1):115-7. PubMed ID: 8673043
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune thrombocytopenia following peripheral blood stem cell autografting.
Ashihara E; Shimazaki C; Hirata T; Okawa K; Oku N; Goto H; Inaba T; Fujita N; Nakagawa M
Bone Marrow Transplant; 1993 Sep; 12(3):297-9. PubMed ID: 7902157
[TBL] [Abstract][Full Text] [Related]
16. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
17. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity following haematopoietic stem-cell transplantation.
Daikeler T; Tyndall A
Best Pract Res Clin Haematol; 2007 Jun; 20(2):349-60. PubMed ID: 17448966
[TBL] [Abstract][Full Text] [Related]
19. Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma.
Lokhorst HM; Sonneveld P; Cornelissen JJ; Joosten P; van Marwijk Kooy M; Meinema J; Nieuwenhuis HK; van Oers MH; Richel DJ; Segeren CN; Veth G; Verdonck LF; Wijermans PW
Bone Marrow Transplant; 1999 Feb; 23(4):317-22. PubMed ID: 10100574
[TBL] [Abstract][Full Text] [Related]
20. Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation.
Sevilla J; Rodríguez A; Hernández-Maraver D; de Bustos G; Aguado J; Ojeda E; Arrieta R; Hernández-Navarro F
Ann Hematol; 2002 Jan; 81(1):11-5. PubMed ID: 11807629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
